medical device investing AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
medical device investing AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
medical device investing AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
medical device investing AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
medical device investing Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
pharmaceutical investing Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
medical device investing Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
